“…This substrate has three electrophilic centers allowing its use in [4 + 1], [3 + 2], and [3 + 3] cyclocondensation processes, as shown in Scheme 1. [14][15][16][17][18] Our ongoing interest in producing and understanding the biological activities of halogenated heterocyclic systems led us to study strategies for synthesizing a diversity of biheterocyclic systems, such as 5-[2-(trifluoromethylheteroaryl)-ethyl]-1,3,4-oxadiazoles (4)(5)(6)(7), with an ethylene spacer between heterocyclic nuclei, from methyl 3-(trifluoromethylheteroaryl)propanoates, where trifluoromethylheteroaryl is 5(3)-trifluoromethyl-1H-pyrazol-3(5)-yl, 2-phenyl-6-trifluoromethyl pyrimidin-4-yl, Vol. 28, No.…”